quality of care

Research in Review

CAR-T Therapy Highly Effective in Treatment-Resistant CLL

07/18/2017

JCP Editors

A recent study reported an overall response rate (ORR) of 71% in patients with chronic lymphocytic leukemia (CLL) treated with anti-CD19 chimeric antigen receptor-modified T (CAR-T) cell therapy after prior treatment...

A...

07/18/2017

Journal of Clinical Pathways

Research in Review

Altered B-Cell Composition May Impact Immunotherapy Effectiveness in AML

07/13/2017

JCP Editors

Initial chemotherapy often alters B-cell composition and immunity in patients with acute myeloid leukemia (AML), which may have implications for the success of further immunotherapy, according to research published...

...

07/13/2017

Journal of Clinical Pathways

Research in Review

Immunotherapy Shows Promise in Rare Type of Lymphoma

07/11/2017

JCP Editors

A recent report demonstrates the promise of programmed death (PD-1) inhibition in improving outcomes for patients with a rare, difficult-to-treat type of lymphoma, published in The New England Journal of Medicine...

A...

07/11/2017

Journal of Clinical Pathways

Research in Review

CAR-T Therapy Response Independent of Disease Factors in NHL

07/10/2017

JCP Editors

A recent clinical trial of a chimeric antigen receptor (CAR) T-cell therapy showed a significantly high response rate in treatment-resistant and relapsed aggressive non-Hodgkin lymphoma (NHL) independent of disease...

A...

07/10/2017

Journal of Clinical Pathways

Research in Review

Does Intensified Therapy Improve Prognosis in DLBCL?

07/03/2017

JCP Editors

Recent research compared the effects of standard chemotherapy dosage with intensified chemotherapy for patients with high-risk diffuse large B-cell lymphoma (DLBCL), published in The Lancet Oncology (published online...

Recent...

07/03/2017

Journal of Clinical Pathways

Research in Review

Blood Flow Measurement Predicts Effectiveness of Ovarian Cancer Treatment

07/03/2017

JCP Editors

A tool for measuring blood flow and volume to ovarian cancer tumors accurately predicts the effectiveness of treatment, according to a recent study published in Clinical Cancer Research (June 2017;...

A tool...

07/03/2017

Journal of Clinical Pathways

Research in Review

Chronic Cancer Survivors in Need of Improved Survivorship Care Plans

06/30/2017

JCP Editors

Survivors of chronic cancer are often not receiving optimal survivorship care plans and follow-up treatment, according to a study published in Cancer (published online June 27, 2017;...

...

06/30/2017

Journal of Clinical Pathways

Research in Review

Risk Stratification, Therapy Intensification Improves Prognosis in Adult ALL

06/29/2017

JCP Editors

Adult patients with a type of acute lymphoblastic leukemia (ALL) may benefit from the use of response-based risk stratification and therapy intensification used in pediatric disease. Early thymic precursor (ETP)-ALL...

Adult...

06/29/2017

Journal of Clinical Pathways

Research in Review

Post-Surgery Complications for Gastric Cancer Significantly Raise Hospital Costs

06/29/2017

JCP Editors

Major complications following total gastrectomy for gastric adenocarcinoma can triple the amount of standard hospital costs, according to research published in JAMA Surgery (published online June 28, 2017;...

Major...

06/29/2017

Journal of Clinical Pathways

Research in Review

High Rates of Chronic Opioid Use Persist in Older Patients With RA

06/29/2017

JCP Editors

Despite a small decline in chronic opioid use after 2010, recent research suggests that 40% of older patients with rheumatoid arthritis (RA) still take opioids regularly as of 2014, published in Arthritis &...

...

06/29/2017

Journal of Clinical Pathways